Academic literature on the topic 'Antiemetic guideline'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Antiemetic guideline.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Antiemetic guideline"

1

Aogi, Kenjiro, Hideki Takeuchi, Toshiaki Saeki, et al. "Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015 Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis." International Journal of Clinical Oncology 26, no. 1 (2020): 1–17. http://dx.doi.org/10.1007/s10147-020-01818-3.

Full text
Abstract:
AbstractPatients with cancer should appropriately receive antiemetic therapies against chemotherapy-induced nausea and vomiting (CINV). Antiemetic guidelines play an important role in managing CINV. Accordingly, the first Japanese antiemetic guideline published in 2010 by the Japan Society of Clinical Oncology (JSCO) has considerably aided Japanese medical staff in providing antiemetic therapies across chemotherapy clinics. With the yearly advancements in antiemetic therapies, the Japanese antiemetic guidelines require revisions according to published evidence regarding antiemetic management w
APA, Harvard, Vancouver, ISO, and other styles
2

Kadakia, Kunal C., Alexis D. Leal, Drew K. Seisler, et al. "Antiemetic prescribing practices using a computerized physician order entry system." Journal of Clinical Oncology 31, no. 15_suppl (2013): e17538-e17538. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e17538.

Full text
Abstract:
e17538 Background: Adherence to guideline-consistent chemotherapy-induced nausea and vomiting (CINV) prophylaxis is suboptimal. The primary aim of this study was to evaluate the magnitude of compliance to institutional guideline-directed antiemetic prophylaxis using a computerized physician order entry system at a single tertiary care institution. A nurse survey was also performed to evaluate how oncology practices, within a cooperative group, manage clinician orders for the prevention of CINV. Methods: The electronic medical records of 100 consecutive patients were evaluated. The primary endp
APA, Harvard, Vancouver, ISO, and other styles
3

Basch, Ethan, Paul J. Hesketh, Mark G. Kris, Ann Alexis Prestrud, Sarah Temin, and Gary H. Lyman. "Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update." Journal of Oncology Practice 7, no. 6 (2011): 395–98. http://dx.doi.org/10.1200/jop.2011.000397.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hesketh, Paul J., Mark G. Kris, Ethan Basch, et al. "Antiemetics: ASCO Guideline Update." Journal of Clinical Oncology 38, no. 24 (2020): 2782–97. http://dx.doi.org/10.1200/jco.20.01296.

Full text
Abstract:
PURPOSE To update the guideline to include new anticancer agents, antiemetics, and antiemetic regimens and to provide recommendations on the use of dexamethasone as a prophylactic antiemetic in patients receiving checkpoint inhibitors (CPIs). METHODS ASCO convened an Expert Panel and updated the systematic review to include randomized controlled trials (RCTs) and meta-analyses of RCTs published between June 1, 2016, and January 24, 2020. To address the dexamethasone and CPI question, we conducted a systematic review of RCTs that evaluated the addition of a CPI to chemotherapy. RESULTS The syst
APA, Harvard, Vancouver, ISO, and other styles
5

Childs, Daniel, and Aminah Jatoi. "Adherence to anti-emetic guidelines with a newly approved chemotherapy agent, trifluridine/tipiracil (TAS-102): A single-institution study." Journal of Clinical Oncology 34, no. 26_suppl (2016): 221. http://dx.doi.org/10.1200/jco.2016.34.26_suppl.221.

Full text
Abstract:
221 Background: To our knowledge, no study has examined adherence to antiemetic guidelines with soon-to-be-approved or newly approved chemotherapy agents. In 2015, the Food and Drug Administration approved 18 cancer drugs, underscoring the timeliness of this topic. Here, we hypothesize that patients prescribed new drugs are at risk for poor guideline adherence, and we report on antiemetic prescribing practices and outcomes with TAS-102, a recently approved drug for metastatic colorectal cancer. Methods: This study focused on all patients prescribed TAS-102 in 2015 at the Mayo Clinic in Rochest
APA, Harvard, Vancouver, ISO, and other styles
6

Copher, Ronda, Russell L. Knoth, Glenn Magee, Soamnauth Misir, and Ali McBride. "Chemotherapy induced nausea and vomiting in breast cancer treated with antiemetic prophylaxis as recommended by the ASCO antiemesis guidelines." Journal of Clinical Oncology 35, no. 15_suppl (2017): 10109. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.10109.

Full text
Abstract:
10109 Background: Current ASCO Antiemesis Guidelines recommend triple antiemetic therapy (a 5HT3RA, an NK1, and dexamethasone) to prevent chemotherapy (CT) induced nausea and vomiting (CINV) in patients undergoing highly emetogenic chemotherapy (HEC). This study evaluated whether this regimen resulted in reduced rates of CINV in patients diagnosed with breast cancer (BC) and initiated on HEC. The primary outcomes of interest were rates of acute and delayed CINV in patients whose antiemesis prophylaxis was or was not in accordance with the ASCO guideline (i.e., Per-guideline vs. Non-Guideline).
APA, Harvard, Vancouver, ISO, and other styles
7

Hesketh, Paul J., Matti Aapro, Karin Jordan, Lee Schwartzberg, Snezana Bosnjak, and Hope Rugo. "A Review of NEPA, a Novel Fixed Antiemetic Combination with the Potential for Enhancing Guideline Adherence and Improving Control of Chemotherapy-Induced Nausea and Vomiting." BioMed Research International 2015 (2015): 1–12. http://dx.doi.org/10.1155/2015/651879.

Full text
Abstract:
Combination antiemetic regimens targeting multiple molecular pathways associated with emesis have become the standard of care for prevention of chemotherapy-induced nausea and vomiting (CINV) related to highly and moderately emetogenic chemotherapies. Antiemetic consensus guidelines from several professional societies are widely available and updated regularly as new data emerges. Unfortunately, despite substantial research supporting the notion that guideline conformity improves CINV control, adherence to antiemetic guidelines is unsatisfactory. While studies are needed to identify specific b
APA, Harvard, Vancouver, ISO, and other styles
8

Patil, Vijay M., Vanita Noronha, Amit Joshi, et al. "Adherence to and Implementation of ASCO Antiemetic Guidelines in Routine Practice in a Tertiary Cancer Center in India." Journal of Oncology Practice 13, no. 6 (2017): e574-e581. http://dx.doi.org/10.1200/jop.2016.019448.

Full text
Abstract:
Background: Nonadherence of antiemetic prescriptions to evidence-based antiemetic guidelines is associated with an increased proportion of chemotherapy-induced nausea and vomiting. The current project was carried out to improve the quality of antiemetic prescriptions at our institute. Methods: We initially performed a retrospective analysis of 1,211 consecutive antiemetic prescription records of adult patients with solid tumors who received outpatient chemotherapy regimens. The antiemetic prescription records were classified as either ASCO-guideline adherent or nonadherent, and the impact on e
APA, Harvard, Vancouver, ISO, and other styles
9

Bosnjak, Snezana, Ana Zilic, and Bishal Gyawali. "Disparities in the availability of and access to antiemetics recommended by the international antiemetic guidelines in Serbia, Japan, and Nepal." Journal of Clinical Oncology 34, no. 26_suppl (2016): 117. http://dx.doi.org/10.1200/jco.2016.34.26_suppl.117.

Full text
Abstract:
117 Background: Guideline-consistent antiemetic therapy requires 4 classes of antiemetics (AEs) to be available and accessible for the optimal prevention of chemotherapy induced nausea and vomiting (CINV): serotonin3 receptor antagonists (5HT3RAs), neurokinin 1 receptor antagonists (NK1RAs), dopamine receptor antagonists (DOPRAs) and dexamethasone. To evaluate disparities in the availability and accessibility of AEs recommended by the international antiemetic guidelines for the prevention of CINV inpatients treated in governmental hospitals in Nepal (low), Serbia (upper-middle) and Japan (high
APA, Harvard, Vancouver, ISO, and other styles
10

Hesketh, Paul J., Mark G. Kris, Ethan Basch, et al. "Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update." Journal of Clinical Oncology 35, no. 28 (2017): 3240–61. http://dx.doi.org/10.1200/jco.2017.74.4789.

Full text
Abstract:
Purpose To update the ASCO guideline for antiemetics in oncology. Methods ASCO convened an Expert Panel and conducted a systematic review of the medical literature for the period of November 2009 to June 2016. Results Forty-one publications were included in this systematic review. A phase III randomized controlled trial demonstrated that adding olanzapine to antiemetic prophylaxis reduces the likelihood of nausea among adult patients who are treated with high emetic risk antineoplastic agents. Randomized controlled trials also support an expanded role for neurokinin 1 receptor antagonists in p
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Antiemetic guideline"

1

Bun, Seiko. "Analysis of concordance with antiemetic guidelines in pediatric, adolescent, and young adult patients with cancer using a large-scale administrative database." Kyoto University, 2020. http://hdl.handle.net/2433/253219.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Antiemetic guideline"

1

Hain, Richard D. W., and Satbir Singh Jassal. Nausea and vomiting. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198745457.003.0008.

Full text
Abstract:
The management of nausea and vomiting requires an understanding of the probable mechanism and logical consideration of drug selection. But it also requires an approach that is individualized to the emotional and psychological needs of the child and family. This chapter examines the pathophysiology of vomiting, alongside guidelines for management and antiemetic therapy. Medications for use to control the symptoms of nausea and vomiting are covered, as well as guidance on exploring and managing the expectations of the patient and family.
APA, Harvard, Vancouver, ISO, and other styles
2

Grech, Dennis, and Laurence M. Hausman. Anesthetic Techniques. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190495756.003.0004.

Full text
Abstract:
Anesthetic techniques for procedures performed outside the traditional operating room are varied. General anesthesia, sedation, and regional anesthesia can all be delivered in this venue. The choice of technique is based on safety considerations and patient comorbidities. Perioperative monitoring such as pulse oximetry, end-tidal carbon dioxide monitoring, and electrocardiography and blood pressure monitoring protocols must be consistent with American Society of Anesthesiologists guidelines. Common procedures include elective office-based anesthetics, emergency room sedations, endoscopic retro
APA, Harvard, Vancouver, ISO, and other styles
3

Provan, Drew, Trevor Baglin, Inderjeet Dokal, and Johannes de Vos. Protocols and procedures. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199683307.003.0015.

Full text
Abstract:
Acute leukaemia: investigations - Platelet reactions and refractoriness - Prophylactic regimen for neutropenic patients - Guidelines for use of IV antibiotics in neutropenic patients - Treatment of neutropenic sepsis: source unknown - Treatment of neutropenic sepsis: source known/suspected - Prophylaxis for patients treated with purine analogues - Tumour lysis syndrome - Administration of chemotherapy - Antiemetics for chemotherapy - Intrathecal chemotherapy - Management of extravasation - Specific procedures after extravasation of cytotoxics commonly used in haematology - Anticoagulation ther
APA, Harvard, Vancouver, ISO, and other styles
4

Provan, Drew, Trevor Baglin, Inderjeet Dokal, Johannes de Vos, and Mammit Kaur. Protocols and procedures. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199683307.003.0015_update_001.

Full text
Abstract:
Acute leukaemia: investigations - Platelet reactions and refractoriness - Prophylactic regimen for neutropenic patients - Guidelines for use of IV antibiotics in neutropenic patients - Treatment of neutropenic sepsis: source unknown - Treatment of neutropenic sepsis: source known/suspected - Prophylaxis for patients treated with purine analogues - Tumour lysis syndrome - Administration of chemotherapy - Antiemetics for chemotherapy - Intrathecal chemotherapy - Management of extravasation - Specific procedures after extravasation of cytotoxics commonly used in haematology - Anticoagulation ther
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!